InvestorsHub Logo
Followers 29
Posts 1802
Boards Moderated 0
Alias Born 04/23/2013

Re: None

Tuesday, 09/20/2016 8:18:04 PM

Tuesday, September 20, 2016 8:18:04 PM

Post# of 158400
"To date, no one in the world has reported the discovery of molecules, natural or synthetic, which activate or inhibit NR2F6 except Regen."

This is going to be the next to rare diseases! IMO and BMSN owns the majority of RGBP shares!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.